Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.
2.

Accuracy of commercial and reference susceptibility testing methods for detecting vancomycin-intermediate Staphylococcus aureus.

Swenson JM, Anderson KF, Lonsway DR, Thompson A, McAllister SK, Limbago BM, Carey RB, Tenover FC, Patel JB.

J Clin Microbiol. 2009 Jul;47(7):2013-7. doi: 10.1128/JCM.00221-09. Epub 2009 May 6.

3.

Comparison of method-specific vancomycin minimum inhibitory concentration values and their predictability for treatment outcome of meticillin-resistant Staphylococcus aureus (MRSA) infections.

Hsu DI, Hidayat LK, Quist R, Hindler J, Karlsson A, Yusof A, Wong-Beringer A.

Int J Antimicrob Agents. 2008 Nov;32(5):378-85. doi: 10.1016/j.ijantimicag.2008.05.007. Epub 2008 Aug 12.

PMID:
18701261
5.

Methicillin-resistant Staphylococcus aureus with reduced susceptibility to vancomycin in Canada.

Webster D, Rennie RP, Brosnikoff CL, Chui L, Brown C.

Diagn Microbiol Infect Dis. 2007 Feb;57(2):177-81. Epub 2006 Aug 28.

PMID:
16938420
6.

Occurrence of vancomycin-intermediate-resistant Staphylococcus aureus in Japan.

Hanaki H, Hososaka Y, Yanagisawa C, Otsuka Y, Nagasawa Z, Nakae T, Sunakawa K.

J Infect Chemother. 2007 Apr;13(2):118-21. Epub 2007 May 8.

PMID:
17458681
7.
8.

Underestimation of vancomycin and teicoplanin MICs by broth microdilution leads to underdetection of glycopeptide-intermediate isolates of Staphylococcus aureus.

Vaudaux P, Huggler E, Bernard L, Ferry T, Renzoni A, Lew DP.

Antimicrob Agents Chemother. 2010 Sep;54(9):3861-70. doi: 10.1128/AAC.00269-10. Epub 2010 Jun 14.

9.

Detection of vancomycin resistant Staphylococcus aureus: a comparative study of three different phenotypic screening methods.

Bhateja P, Mathur T, Pandya M, Fatma T, Rattan A.

Indian J Med Microbiol. 2005 Jan;23(1):52-5.

10.

Vancomycin MICs for Staphylococcus aureus vary by detection method and have subtly increased in a pediatric population since 2005.

Mason EO, Lamberth LB, Hammerman WA, Hulten KG, Versalovic J, Kaplan SL.

J Clin Microbiol. 2009 Jun;47(6):1628-30. doi: 10.1128/JCM.00407-09. Epub 2009 Apr 29.

11.
12.

Differences in vancomycin minimum inhibitory concentrations for Staphylococcus aureus obtained with the automated Phoenix™ system, the Clinical and Laboratory Standards Institute broth microdilution method and the standard Etest.

Muñoz-Cobo B, Sancho-Tello S, Costa E, Bravo D, Torregrosa I, de Lomas JG, Navarro D.

Int J Antimicrob Agents. 2011 Mar;37(3):278-9. doi: 10.1016/j.ijantimicag.2010.12.004. Epub 2011 Jan 26. No abstract available.

PMID:
21269809
13.

Methicillin-resistant Staphylococcus aureus heterogeneously resistant to vancomycin in a Turkish university hospital.

Sancak B, Ercis S, Menemenlioglu D, Colakoglu S, Hasçelik G.

J Antimicrob Chemother. 2005 Sep;56(3):519-23. Epub 2005 Jul 26.

PMID:
16046461
14.

Detection of Staphylococcus aureus isolates with heterogeneous intermediate-level resistance to vancomycin in the United States.

Richter SS, Satola SW, Crispell EK, Heilmann KP, Dohrn CL, Riahi F, Costello AJ, Diekema DJ, Doern GV.

J Clin Microbiol. 2011 Dec;49(12):4203-7. doi: 10.1128/JCM.01152-11. Epub 2011 Oct 5.

15.
16.

Evaluation of the Etest GRD for the detection of Staphylococcus aureus with reduced susceptibility to glycopeptides.

Leonard SN, Rossi KL, Newton KL, Rybak MJ.

J Antimicrob Chemother. 2009 Mar;63(3):489-92. doi: 10.1093/jac/dkn520. Epub 2009 Jan 9.

PMID:
19136530
17.

Antimicrobial activity of daptomycin tested against Staphylococcus aureus with vancomycin MIC of 2 microg/mL isolated in the United States and European hospitals (2006-2008).

Sader HS, Becker HK, Moet GJ, Jones RN.

Diagn Microbiol Infect Dis. 2010 Mar;66(3):329-31. doi: 10.1016/j.diagmicrobio.2009.09.017.

PMID:
20159377
18.

Correlation between vancomycin and daptomycin MIC values for methicillin-susceptible and methicillin-resistant Staphylococcus aureus by 3 testing methodologies.

Keel RA, Sutherland CA, Aslanzadeh J, Nicolau DP, Kuti JL.

Diagn Microbiol Infect Dis. 2010 Nov;68(3):326-9. doi: 10.1016/j.diagmicrobio.2010.08.006.

PMID:
20955917
19.

Detection of intermediately vancomycin-susceptible and heterogeneous Staphylococcus aureus isolates: comparison of Etest and Agar screening methods.

Riederer K, Shemes S, Chase P, Musta A, Mar A, Khatib R.

J Clin Microbiol. 2011 Jun;49(6):2147-50. doi: 10.1128/JCM.01435-10. Epub 2011 Apr 13.

20.

Contribution of selected gene mutations to resistance in clinical isolates of vancomycin-intermediate Staphylococcus aureus.

Hafer C, Lin Y, Kornblum J, Lowy FD, Uhlemann AC.

Antimicrob Agents Chemother. 2012 Nov;56(11):5845-51. doi: 10.1128/AAC.01139-12. Epub 2012 Sep 4.

Supplemental Content

Support Center